- External
oversight of the unregulated fertility industry in the United States and
stronger consumer protections.
- Increased
research to track the health and wellbeing of women undergoing Assisted
Reproductive Technologies - ART's, including egg donors and surrogates.
- Increased
research to track the health of infants born from these technologies.
- Amending
the 1992 Fertility Clinic Success Rate and Certification
Act. Clinics should be required to adhere to
standardized calculation and reporting methods that enable reproductive
health consumers to more accurately ascertain ART failure and success
rates, including the need for each clinic to post the total number of
cycles per woman.
- Reversing
the growing epidemic of public misinformation about women’s fertility
peaks and declines that leads to involuntary childlessness.
- Providing
more balanced public information about the limits and potential of
Assisted Reproductive Technologies. Doctors, especially gynecologists, to
speak candidly with their reproductive age patients about the biological
facts about women’s fertility peaks and declines, and the limitations of
reproductive medicine to reverse infertility.